Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



30 Billion Potential Reasons to Love Merck & Co., Inc.

Money is flying fast in health care as big pharma's swap units and look to acquire each other. As they say, where there is smoke there is fire, and there is a lot of smoke emanating from Merck (NYSE: MRK  ) .

The big pharma's consumer division, which includes well known brands like Coppertone and Dr. Scholl's, has been rumored to be on the block for months and the numbers around the secret bidding keep getting higher, and are now in the $14 billion range. As a result, one of its ardent suitors has walked away, leaving potentially a single finalist.

However, Merck may not be done. The newest rumor is that its established products unit, these are off patent drugs, is also in play, and could fetch another $15 billion.

In this episode of Market Check-Up, the Motley Fool's health-care focused investing show, analysts David Williamson and Michael Douglass discuss the details of these 2 rumors and what they mean for investors.

Watch the video below and find out why Merck would be even more exciting if it can pull off nearly $30 billion in asset sales.

Warren Buffett just bought nearly 9 million shares of this company
Imagine a company that rents a very specific and valuable piece of machinery for $41,000... per hour (that's almost as much as the average American makes in a year!). And Warren Buffett is so confident in this company's can't-live-without-it business model, he just loaded up on 8.8 million shares. An exclusive, brand-new Motley Fool report details this company that already has over 50% market share. Just click HERE to discover more about this industry-leading stock... and join Buffett in his quest for a veritable landslide of profits!


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2943858, ~/Articles/ArticleHandler.aspx, 8/31/2015 2:13:07 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

David Williamson

The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...

Today's Market

updated Moments ago Sponsored by:
DOW 16,546.13 -96.88 -0.58%
S&P 500 1,978.06 -10.81 -0.54%
NASD 4,798.35 -29.97 -0.62%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/31/2015 1:57 PM
MRK $54.04 Down -1.33 -2.40%
Merck & Co., Inc. CAPS Rating: ****
BAYRY $135.43 Down -0.59 -0.43%
Bayer AG (ADR) CAPS Rating: ****
RBGLY $17.78 Down -0.14 -0.78%
Reckitt Benckiser CAPS Rating: *****